SCHEMBL31728923

SCHEMBL31728923

Cc1nccc(C(C)Oc2cnc(-c3ccc(F)c(Cl)c3F)c3ncnc(N)c23)n1

nearest known ligand 0.36

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.36
▸ MET P08581 13/20 0.35
▸ JAK2 O60674 1/20 0.33
▸ ALK Q9UM73 1/20 0.31
▸ ALOX5AP P20292 1/20 0.30
▸ FEN1 P39748 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31728571 0.80 MET (0.35) METJAK2ALK
SCHEMBL31729165 0.80 MET (0.35) METJAK2ALK
SCHEMBL31729160 0.77 MET (0.33) METALK
SCHEMBL31727907 0.75 POLB (0.41) POLBJAK2
SCHEMBL31728939 0.75 POLB (0.41) POLBJAK2
SCHEMBL31727934 0.74 ALK (0.33) METALK
SCHEMBL31729172 0.73 MET (0.37) METJAK2ALK
SCHEMBL31727899 0.72 PIK3CD (0.31) —
SCHEMBL31728875 0.72 SLC6A4 (0.38) ALOX5APFEN1
SCHEMBL31727874 0.71 CLK1 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235874-A1 HETEROCYCLICS AS EGFR INHIBITORS SCHRÖDINGER, INC. (US) 2025-11-13 — — WO disclosed
Send feedback